Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Azvudine in the Treatment of Patients With Corona Virus Disease (COVID-19) Pneumonia in China: an Multi-center Observational, Ambispective Cohort, Real-world Study

NCT05621993 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05621993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Azvudine in the Treatment of Patients With Corona Virus Disease (COVID-19) Pneumonia in China: an Multi-center Observational, Ambispective Cohort, Real-world Study
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 22, 2022
Completion date
December 31, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 respiratory infection